Income Taxes (Details Narrative) - USD ($) |
12 Months Ended | ||||
|---|---|---|---|---|---|
Dec. 22, 2017 |
Dec. 08, 2017 |
Nov. 07, 2016 |
Dec. 31, 2017 |
Dec. 31, 2016 |
|
| Income Tax Disclosure [Abstract] | |||||
| Valuation allowance | $ 6,005,000 | ||||
| Change in valuation allowance | 213,000 | ||||
| Operating loss carryforwards for federal and state income tax | $ 20,507,000 | ||||
| Expiration of operating loss carryforwards | Dec. 31, 2034 | ||||
| Annual limitation of net operating loss through 2021 | $ 1,800,000 | ||||
| Annual limitation of net operating loss after 2021 | $ 273,000 | ||||
| Number of common shares issued | 18,200 | 1,777,417 | 312,500 | 1,777,417 | |
| Income tax description | Reduction of the corporate tax rate from 35% to 21%, we re-measured our net deferred tax liability at the lower corporate rate of 21% and recognized a $788,000 tax benefit to adjust net deferred tax assets to the reduced value. | ||||
| Corporate tax rate | 35.00% | 7.30% | 23.90% | ||
| Corporate tax rate reductions | 21.00% | ||||
| Tax benefit re-measured amount | $ 788,000 | ||||
| Undistributed foreign E&P amount | $ 332,000 | ||||
| X | ||||||||||
- Definition Annual limitation of net operating loss after year five. No definition available.
|
| X | ||||||||||
- Definition Annual limitation of net operating loss through year five. No definition available.
|
| X | ||||||||||
- Definition Tax benefit remeasured amount. No definition available.
|
| X | ||||||||||
- Definition Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deductions. Including, but not limited to, extraterritorial income exclusion deduction, qualified production activity deduction, dividend deduction, deduction for dividend paid to employee stock ownership plan, Medicare prescription drug benefit subsidy deduction, and other deductions. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to repatriation of foreign earnings. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Expiration date of each operating loss carryforward included in operating loss carryforward, in CCYY-MM-DD format. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|